CRIS Current Research Information System

MONTANARO, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.370
AS - Asia 4.141
EU - Europa 3.578
Continente sconosciuto - Info sul continente non disponibili 223
SA - Sud America 219
AF - Africa 211
OC - Oceania 11
Totale 13.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.262
SG - Singapore 1.109
VN - Vietnam 1.080
IT - Italia 1.028
CN - Cina 1.016
GB - Regno Unito 781
DE - Germania 425
SE - Svezia 295
HK - Hong Kong 278
UA - Ucraina 261
FR - Francia 210
IN - India 177
RU - Federazione Russa 171
BR - Brasile 152
IE - Irlanda 109
JP - Giappone 105
KR - Corea 94
BD - Bangladesh 92
NL - Olanda 67
CI - Costa d'Avorio 64
ZA - Sudafrica 62
CA - Canada 54
FI - Finlandia 48
EE - Estonia 39
BE - Belgio 33
JO - Giordania 31
PH - Filippine 31
TG - Togo 31
AR - Argentina 26
MX - Messico 22
GR - Grecia 20
AT - Austria 18
SC - Seychelles 18
TR - Turchia 18
ID - Indonesia 17
NG - Nigeria 15
IR - Iran 14
CH - Svizzera 13
CO - Colombia 12
PK - Pakistan 12
AU - Australia 11
EC - Ecuador 11
IQ - Iraq 11
TH - Thailandia 11
PL - Polonia 10
TW - Taiwan 10
HR - Croazia 9
BG - Bulgaria 7
CR - Costa Rica 7
UZ - Uzbekistan 7
CL - Cile 6
JM - Giamaica 6
LT - Lituania 6
VE - Venezuela 6
AL - Albania 5
ES - Italia 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
SA - Arabia Saudita 5
EG - Egitto 4
HN - Honduras 4
KE - Kenya 4
TN - Tunisia 4
CZ - Repubblica Ceca 3
GT - Guatemala 3
LB - Libano 3
MA - Marocco 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
KZ - Kazakistan 2
NP - Nepal 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AO - Angola 1
BB - Barbados 1
BT - Bhutan 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SY - Repubblica araba siriana 1
Totale 13.529
Salva come PNG Salva come JPEG
Città #
Singapore 751
Southend 656
Ashburn 417
San Jose 394
Santa Clara 377
Chandler 339
Fairfield 293
Hong Kong 269
Dong Ket 239
Ho Chi Minh City 210
Hefei 207
Jacksonville 200
Council Bluffs 198
Princeton 183
Wilmington 171
Hanoi 160
Houston 139
Woodbridge 137
Ann Arbor 135
Seattle 134
Dallas 116
Los Angeles 107
Dublin 106
Beijing 105
Tokyo 95
Cambridge 93
Boardman 90
Lauterbourg 86
Seoul 84
New York 70
Padova 69
Westminster 68
Bologna 66
Abidjan 64
Nanjing 62
Rome 61
Milan 60
Buffalo 46
Mülheim 45
Helsinki 42
Berlin 39
Bremen 39
Medford 37
Saint Petersburg 35
Shenyang 34
Amman 31
Lomé 31
Haiphong 30
Phoenix 30
Brussels 29
Da Nang 28
San Diego 26
San Venanzo 26
Florence 25
Hebei 25
Atlanta 24
Shanghai 24
Nanchang 23
Jinan 22
Munich 22
Frankfurt am Main 21
Redondo Beach 20
Changsha 19
Guangzhou 19
Jiaxing 19
Palermo 19
The Dalles 19
Chicago 17
Mahé 17
São Paulo 17
London 16
Zhengzhou 15
Bengaluru 14
Dearborn 14
Montreal 14
Olalla 14
Orem 14
San Francisco 14
Abeokuta 13
Shenzhen 13
Tianjin 13
Wuhan 13
Biên Hòa 12
Turin 12
Pescara 11
Verona 11
Brooklyn 10
Denver 10
Fuzhou 10
Ningbo 10
Norwalk 10
Nuremberg 10
Bến Tre 9
Chennai 9
Falkenstein 9
Falls Church 9
Hangzhou 9
Kunming 9
Las Vegas 9
Naples 9
Totale 8.256
Salva come PNG Salva come JPEG
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 653
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 324
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions 299
Le basi della farmacologia 293
A 3 year survey on the use of antibacterial agents in five Italian hospitals. 236
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 228
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 221
Ticlopidine Safety Profile: A Case/Non-Case Study on the Basis of the Spontaneous ADRs Reporting in Italy 220
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 218
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature 214
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). 203
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database 201
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. 198
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 198
An update on the first decade of the European centralized procedure: how many innovative drugs? 197
Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database 195
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 195
Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase). 194
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 192
Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug’s safety profile. 185
Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System 184
Comparative Safety Profiles of Biosimilars vs. Originators Used in Rheumatology: A Pharmacovigilance Analysis of the EudraVigilance Database 183
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics 183
Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data 178
Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database 175
Non-commercial trials on medicines submitted to the Ethics Committee of the University Hospital of Bologna (Italy) along 8 years of activity: time to update rules and recommendations 169
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy 166
Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice. 165
Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations 165
Antibiotic use in Italian hospitals 2002-2004. 164
Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy 164
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. 164
Hepatic adverse drug reactions: a case/non-case study in Italy 163
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 162
The adherence to antihypertensive treatments: an Italian survey by using prescription databases. 159
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 158
Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy 157
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 157
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 155
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 154
Level of therapeutic innovation from the registration studies of the new drugs for the prophylaxis of migraine 152
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 152
Therapeutic innovation of the drugs approved by the EMEA-centralised procedure 151
Initial treatment of hypertension and adherence to therapy in general practice in Italy 151
Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara. 150
La rimborsabilità di memantina - il trilemma di Münchausen 150
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 150
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 147
Progetto europeo di confronto dell'uso dei farmaci 146
Un commento alla lettera sulla definizione di farmaco innovativo 145
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures 143
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. 143
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. 139
Farmaci EMEA ed innovazione terapeutica 139
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 139
Safety profile of paediatric COVID-19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System 135
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 134
The Influence of Notoriety Bias on ADR Spontaneous Reporting Rate. 131
Pattern of Triptan Use in a Sample of the Italian General Population 131
Natalizumab: a country-based surveillance program 131
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice 131
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, 130
Three years of experience: the Italian registry and safety data update 129
Prevenire gli errori in terapia. Strategie per i farmacisti 125
Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna 122
Removal of the EMA orphan designation upon request of the sponsor: cui prodest? 122
Monitoring the use of disease-modifying drugs in multiple sclerosis 118
Ticlopidine’s safety profile: a case/non case study on the basis of the spontaneous ADR reporting in Italy. 117
The Italian Surveillance Program on Natalizumab 115
Prescrizione di Entacapone nella Regione Emilia-Romagna 113
Hepatic adverse drug reactions: analysis of an italian spontaneous reporting database. 108
Monitoring disease-modifying drugs in multiple sclerosis in Emilia Romagna 108
La medicina basata sulle prove - Istruzioni per l'uso. Prima edizione italiana 107
The Italian Natalizumab Registry: a 1-year follow-up 106
La medicina basata sulle prove. Dalle fonti di conoscenza alla realtà del singolo paziente. Seconda edizione 104
Pattern of use of NSAIDs in the Italian general population: a questionnaire-based study 103
Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data 99
Use of benzodiazepines in the Italian general population: Prevalence, pattern of use and risk factors for use 97
Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database 94
On criteria to evaluate the therapeutic innovation of drugs 88
Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis 88
Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on EudraVigilance data 83
Overview of Orphan Medicines in European Union: An Analysis of Regulatory and Technical-Scientific Aspects 78
Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab 74
Use of anti-asthmatic drugs in Italy: Analysis of prescriptions in general practice in the light of guidelines for asthma treatment 55
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: An overview 53
Adverse drug reactions related to the use of fluoroquinolone antimicrobials: An analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions 38
Totale 13.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.101
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.117 0 0 0 98 120 66 25 93 51 91 355 218
2022/20231.483 159 183 100 203 99 128 28 86 261 45 127 64
2023/2024498 46 69 37 60 42 43 32 42 22 39 50 16
2024/20251.731 69 230 143 86 440 132 87 52 30 55 81 326
2025/20264.292 240 370 408 340 502 202 548 176 717 335 249 205
2026/2027979 155 168 373 283 0 0 0 0 0 0 0 0
Totale 13.753